# Werner Enterprises Inc: financial statements, quarterly

WERN · Nasdaq · CIK 793074 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wern.md) · [Financials](/companies/wern/financials.md) · [Filings](/companies/wern/filings.md) · [Insiders](/companies/wern/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wern/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [818](/filings/0000793074-24-000064.md) | [742 d](/filings/0000793074-26-000071.md) | [750](/filings/0000793074-25-000027.md) | [743](/filings/0000793074-25-000044.md) | [726](/filings/0000793074-25-000058.md) | [737 d](/filings/0000793074-26-000071.md) | [693](/filings/0000793074-26-000096.md) | [734](/filings/0000793074-26-000140.md) | [752](/filings/0000793074-25-000058.md) | [720 d](/filings/0000793074-26-000071.md) | [790](/filings/0000793074-26-000096.md) | [914](/filings/0000793074-26-000140.md) |
| Operating income | $m | [37.9](/filings/0000793074-24-000064.md) | [37.9 d](/filings/0000793074-26-000071.md) | [15.6](/filings/0000793074-25-000027.md) | [19.6](/filings/0000793074-25-000044.md) | [17.6](/filings/0000793074-25-000058.md) | [13.4 d](/filings/0000793074-26-000071.md) | [(5.8)](/filings/0000793074-26-000096.md) | [66.3](/filings/0000793074-26-000140.md) | [(13.0)](/filings/0000793074-25-000058.md) | [(35.8) d](/filings/0000793074-26-000071.md) | [4.0](/filings/0000793074-26-000096.md) | [16.9](/filings/0000793074-26-000140.md) |
| Interest expense | $m | [8.7](/filings/0000793074-23-000058.md) | [8.8 d](/filings/0000793074-24-000014.md) | [7.9](/filings/0000793074-24-000037.md) | [9.0](/filings/0000793074-25-000044.md) | [11.1](/filings/0000793074-25-000058.md) | [11.1 d](/filings/0000793074-26-000071.md) | [9.5](/filings/0000793074-26-000096.md) | [9.4](/filings/0000793074-26-000140.md) | [9.9](/filings/0000793074-25-000058.md) | [10.2 d](/filings/0000793074-26-000071.md) | [11.7](/filings/0000793074-26-000096.md) | [11.7](/filings/0000793074-26-000140.md) |
| Income tax | $m | [7.0](/filings/0000793074-24-000064.md) | [7.0 d](/filings/0000793074-26-000071.md) | [3.1](/filings/0000793074-25-000027.md) | [2.9](/filings/0000793074-25-000044.md) | [2.0](/filings/0000793074-25-000058.md) | [0.9 d](/filings/0000793074-26-000071.md) | [(3.2)](/filings/0000793074-26-000096.md) | [15.5](/filings/0000793074-26-000140.md) | [(0.8)](/filings/0000793074-25-000058.md) | [(9.3) d](/filings/0000793074-26-000071.md) | [(1.5)](/filings/0000793074-26-000096.md) | [2.0](/filings/0000793074-26-000140.md) |
| Net income | $m | [23.7](/filings/0000793074-24-000064.md) | [23.6 d](/filings/0000793074-26-000071.md) | [6.3](/filings/0000793074-25-000027.md) | [9.5](/filings/0000793074-25-000044.md) | [6.6](/filings/0000793074-25-000058.md) | [11.9 d](/filings/0000793074-26-000071.md) | [(10.1)](/filings/0000793074-26-000096.md) | [44.1](/filings/0000793074-26-000140.md) | [(20.6)](/filings/0000793074-25-000058.md) | [(27.8) d](/filings/0000793074-26-000071.md) | [(4.3)](/filings/0000793074-26-000096.md) | [6.4](/filings/0000793074-26-000140.md) |
| Diluted EPS | $ per share | [0.37](/filings/0000793074-24-000064.md) | not reported | [0.10](/filings/0000793074-25-000027.md) | [0.15](/filings/0000793074-25-000044.md) | [0.11](/filings/0000793074-25-000058.md) | not reported | [(0.16)](/filings/0000793074-26-000096.md) | [0.72](/filings/0000793074-26-000140.md) | [(0.34)](/filings/0000793074-25-000058.md) | not reported | [(0.07)](/filings/0000793074-26-000096.md) | [0.11](/filings/0000793074-26-000140.md) |
| Basic EPS | $ per share | [0.37](/filings/0000793074-24-000064.md) | not reported | [0.10](/filings/0000793074-25-000027.md) | [0.15](/filings/0000793074-25-000044.md) | [0.11](/filings/0000793074-25-000058.md) | not reported | [(0.16)](/filings/0000793074-26-000096.md) | [0.72](/filings/0000793074-26-000140.md) | [(0.34)](/filings/0000793074-25-000058.md) | not reported | [(0.07)](/filings/0000793074-26-000096.md) | [0.11](/filings/0000793074-26-000140.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [42.8](/filings/0000793074-23-000058.md) | [61.7](/filings/0000793074-25-000009.md) | [60.3](/filings/0000793074-24-000037.md) | [70.4](/filings/0000793074-24-000056.md) | [54.7](/filings/0000793074-24-000064.md) | [40.8](/filings/0000793074-26-000071.md) | [52.0](/filings/0000793074-25-000027.md) | [51.4](/filings/0000793074-25-000044.md) | [51.0](/filings/0000793074-25-000058.md) | [59.9](/filings/0000793074-26-000140.md) | [61.5](/filings/0000793074-26-000096.md) | [57.0](/filings/0000793074-26-000140.md) |
| Current assets | $m | [645](/filings/0000793074-23-000058.md) | [635](/filings/0000793074-25-000009.md) | [597](/filings/0000793074-24-000037.md) | [578](/filings/0000793074-24-000056.md) | [547](/filings/0000793074-24-000064.md) | [542](/filings/0000793074-26-000071.md) | [539](/filings/0000793074-25-000027.md) | [559](/filings/0000793074-25-000044.md) | [605](/filings/0000793074-25-000058.md) | [613](/filings/0000793074-26-000140.md) | [703](/filings/0000793074-26-000096.md) | [675](/filings/0000793074-26-000140.md) |
| Total assets | $m | [3,194](/filings/0000793074-23-000058.md) | [3,158](/filings/0000793074-25-000009.md) | [3,079](/filings/0000793074-24-000037.md) | [3,094](/filings/0000793074-24-000056.md) | [3,122](/filings/0000793074-24-000064.md) | [3,052](/filings/0000793074-26-000071.md) | [2,987](/filings/0000793074-25-000027.md) | [2,946](/filings/0000793074-25-000044.md) | [2,971](/filings/0000793074-25-000058.md) | [2,889](/filings/0000793074-26-000140.md) | [3,256](/filings/0000793074-26-000096.md) | [3,159](/filings/0000793074-26-000140.md) |
| Current liabilities | $m | [330](/filings/0000793074-23-000058.md) | [331](/filings/0000793074-25-000009.md) | [314](/filings/0000793074-24-000037.md) | [342](/filings/0000793074-24-000056.md) | [358](/filings/0000793074-24-000064.md) | [356](/filings/0000793074-26-000071.md) | [324](/filings/0000793074-25-000027.md) | [334](/filings/0000793074-25-000044.md) | [374](/filings/0000793074-25-000058.md) | [315](/filings/0000793074-26-000140.md) | [482](/filings/0000793074-26-000096.md) | [466](/filings/0000793074-26-000140.md) |
| Total liabilities | $m | [1,643](/filings/0000793074-23-000058.md) | [1,591](/filings/0000793074-25-000009.md) | [1,522](/filings/0000793074-24-000037.md) | [1,600](/filings/0000793074-24-000056.md) | [1,635](/filings/0000793074-24-000064.md) | [1,558](/filings/0000793074-26-000071.md) | [1,513](/filings/0000793074-25-000027.md) | [1,489](/filings/0000793074-25-000044.md) | [1,540](/filings/0000793074-25-000058.md) | [1,498](/filings/0000793074-26-000140.md) | [1,876](/filings/0000793074-26-000096.md) | [1,776](/filings/0000793074-26-000140.md) |
| Long-term debt | $m | [686](/filings/0000793074-23-000058.md) | [646](/filings/0000793074-25-000009.md) | [596](/filings/0000793074-24-000037.md) | [660](/filings/0000793074-24-000056.md) | [690](/filings/0000793074-24-000064.md) | [630](/filings/0000793074-26-000071.md) | [640](/filings/0000793074-25-000027.md) | [725](/filings/0000793074-25-000044.md) | [725](/filings/0000793074-25-000058.md) | [752](/filings/0000793074-26-000140.md) | [870](/filings/0000793074-26-000096.md) | [793](/filings/0000793074-26-000140.md) |
| Current portion of debt | $m | [3.8](/filings/0000793074-23-000058.md) | [2.5](/filings/0000793074-25-000009.md) | [1.3](/filings/0000793074-24-000037.md) | [10.0](/filings/0000793074-24-000056.md) | [0.0](/filings/0000793074-24-000064.md) | [20.0](/filings/0000793074-26-000071.md) | [0.0](/filings/0000793074-25-000027.md) | [0.0](/filings/0000793074-25-000044.md) | [0.0](/filings/0000793074-25-000058.md) | [0.0](/filings/0000793074-26-000096.md) | [8.6](/filings/0000793074-26-000096.md) | not reported |
| Shareholders' equity | $m | [1,512](/filings/0000793074-24-000064.md) | [1,528](/filings/0000793074-26-000071.md) | [1,518](/filings/0000793074-25-000044.md) | [1,455](/filings/0000793074-25-000058.md) | [1,449](/filings/0000793074-25-000058.md) | [1,456](/filings/0000793074-26-000140.md) | [1,436](/filings/0000793074-26-000140.md) | [1,421](/filings/0000793074-26-000140.md) | [1,396](/filings/0000793074-25-000058.md) | [1,363](/filings/0000793074-26-000140.md) | [1,353](/filings/0000793074-26-000140.md) | [1,356](/filings/0000793074-26-000140.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [74.2 d](/filings/0000793074-24-000064.md) | [118 d](/filings/0000793074-26-000071.md) | [88.6](/filings/0000793074-25-000027.md) | [109 d](/filings/0000793074-25-000044.md) | [61.0 d](/filings/0000793074-25-000058.md) | [71.0 d](/filings/0000793074-26-000071.md) | [29.4](/filings/0000793074-26-000096.md) | [46.0 d](/filings/0000793074-26-000140.md) | [44.1 d](/filings/0000793074-25-000058.md) | [62.3 d](/filings/0000793074-26-000071.md) | [83.5](/filings/0000793074-26-000096.md) | [83.8 d](/filings/0000793074-26-000140.md) |
| Capital expenditure | $m | [169 d](/filings/0000793074-24-000064.md) | [68.7 d](/filings/0000793074-26-000071.md) | [58.2](/filings/0000793074-25-000027.md) | [140 d](/filings/0000793074-25-000044.md) | [134 d](/filings/0000793074-25-000058.md) | [80.8 d](/filings/0000793074-26-000071.md) | [23.5](/filings/0000793074-26-000096.md) | [88.3 d](/filings/0000793074-26-000140.md) | [52.7 d](/filings/0000793074-25-000058.md) | [85.8 d](/filings/0000793074-26-000071.md) | [52.8](/filings/0000793074-26-000096.md) | [29.0 d](/filings/0000793074-26-000140.md) |
| Dividends paid | $m | [8.9 d](/filings/0000793074-24-000064.md) | [8.9 d](/filings/0000793074-26-000071.md) | [8.9](/filings/0000793074-25-000027.md) | [8.9 d](/filings/0000793074-25-000044.md) | [8.7 d](/filings/0000793074-25-000058.md) | [8.7 d](/filings/0000793074-26-000071.md) | [8.7](/filings/0000793074-26-000096.md) | [8.7 d](/filings/0000793074-26-000140.md) | [8.4 d](/filings/0000793074-25-000058.md) | [8.4 d](/filings/0000793074-26-000071.md) | [8.4](/filings/0000793074-26-000096.md) | [8.4 d](/filings/0000793074-26-000140.md) |
| Share repurchases | $m | [0.0 d](/filings/0000793074-24-000064.md) | [0.0 d](/filings/0000793074-26-000071.md) | [6.6](/filings/0000793074-25-000027.md) | [60.5 d](/filings/0000793074-25-000044.md) | [0.0 d](/filings/0000793074-25-000058.md) | [(0.0) d](/filings/0000793074-26-000071.md) | [0.0](/filings/0000793074-25-000027.md) | [55.6 d](/filings/0000793074-26-000140.md) | [0.0 d](/filings/0000793074-25-000058.md) | [(0.0) d](/filings/0000793074-26-000071.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [63.8](/filings/0000793074-23-000058.md) | [63.7](/filings/0000793074-24-000037.md) | [63.7](/filings/0000793074-24-000056.md) | [63.7](/filings/0000793074-24-000064.md) | [63.7](/filings/0000793074-25-000027.md) | [62.9](/filings/0000793074-25-000044.md) | [62.0](/filings/0000793074-25-000058.md) | [61.9](/filings/0000793074-26-000096.md) | [61.0](/filings/0000793074-26-000140.md) | [59.8](/filings/0000793074-25-000058.md) | [59.9](/filings/0000793074-26-000096.md) | [60.2](/filings/0000793074-26-000140.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 59,977,156 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0000793074-26-000140.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.